Publication Cover
Synthetic Communications
An International Journal for Rapid Communication of Synthetic Organic Chemistry
Volume 53, 2023 - Issue 21
204
Views
1
CrossRef citations to date
0
Altmetric
Synthetic Communications Reviews

Insights into adopted synthetic approaches for 1,2,4-oxadiazoles: A review

ORCID Icon, , , , , , & show all
Pages 1761-1783 | Received 28 Jul 2023, Published online: 07 Sep 2023
 

Abstract

A five-membered heterocyclic compound known as 1,2,4-oxadiazole has one oxygen, two carbon, and two nitrogen atoms within a ring. Numerous studies have shown that 1,2,4-oxadiazole has the potential as a useful pharmacophore in many harmful pharmacological conditions such as microbiocidal, anti-inflammatory, anti-tuberculosis, Meibomian gland dysfunction, etc. In this present review, we highlighted the synthetic protocols (based on the starting substrate) for 1,2,4-oxadiazoles which have been adopted in the last nine years (2015 to 2023). The study also involved a listing of several patents (granted) which comprised important work on 1,2,4-oxadiazole and its derivatives. Among all the methods, the most commonly adopted synthetic methods included the synthesis of 1,2,4-oxadiazoles from amidoxime, nitriles, chloroximes, benzaldehyde, vinyl benzene, benzamides, etc. These synthetic protocols have also been compared based on different reaction conditions, feasibility, and economy to help the researchers in designing their work.

Graphical Abstract

Acknowledgements

Declared none

Disclosure statement

No potential conflict of interest was reported by the author(s).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.